SECsense Logo

Royalty Pharma plc Reports Key SEC Filing 8-K on January 10, 2025

$RPRX
Form 8-K
Filed on: 2025-01-10
Source
Royalty Pharma plc Reports Key SEC Filing 8-K on January 10, 2025

Here are the key insights extracted from the provided section of the financial report:

  1. Entity Information:
  • Company Name: Royalty Pharma plc
  • CIK: 0001802768
  • SEC File Number: 001-39329
  • Tax Identification Number: 98-1535773
  • Address: 110 East 59th Street, New York, NY 10022
  • Phone Number: 212-883-0200
  1. Report Details:
  • Filing Type: 8-K (a report of unscheduled material events or corporate changes)
  • Filing Date: January 10, 2025
  1. Classification of Shares:
  • Type of Shares: Class A Ordinary Shares
  • Par Value: $0.0001 per share
  • Trading Symbol: RPRX
  • Exchange: NASDAQ
  1. Financial Context:
  • Reporting Date: January 10, 2025
  • Currency: USD (United States Dollar)
  • Measurement Units: Report includes both USD and Shares as units of measurement.
  1. Period of Reporting:
  • The report covers a specific date (January 10, 2025) rather than a range, indicating it may pertain to a particular event or announcement relevant to that date.

This section primarily provides identification details of Royalty Pharma plc and indicates an important filing made with the SEC concerning potential significant events affecting the company as of the specified date.